<?xml version="1.0" encoding="UTF-8"?>
<ref id="B189-pharmaceuticals-12-00147">
 <label>189.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Leymarie</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Tafforeau</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Lotteau</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Costa</surname>
    <given-names>B.D.</given-names>
   </name>
   <name>
    <surname>Delmas</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Chevalier</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Le Goffic</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune response</article-title>
  <source>J. Gen. Virol.</source>
  <year>2017</year>
  <volume>98</volume>
  <fpage>1196</fpage>
  <lpage>1208</lpage>
  <pub-id pub-id-type="doi">10.1099/jgv.0.000782</pub-id>
  <?supplied-pmid 28613140?>
  <pub-id pub-id-type="pmid">28613140</pub-id>
 </element-citation>
</ref>
